Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
19-22 October, 2025
Not Confirmed
Not Confirmed
20-22 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
19-22 October, 2025
Industry Trade Show
Not Confirmed
20-22 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-are-building-capabilities-to-stay-ahead-of-the-curve-and-align-with-future-needs-of-global-healthcare
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india
11 Sep 2025
// REUTERS
https://www.reuters.com/legal/litigation/ionis-arrowhead-file-dueling-patent-lawsuits-over-genetic-disorder-drug-2025-09-11/
10 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-10/arrowhead-pharmaceuticals-requests-regulatory-clearance-to-initiate-phase-12a-study-of-aro-mapt-for
03 Sep 2025
// REUTERS
https://www.reuters.com/sustainability/boards-policy-regulation/arrowhead-novartis-up-2-billion-deal-neuromuscular-therapy-license-2025-09-02/
27 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250827483210/en/Arrowhead-Pharmaceuticals-to-Participate-in-Upcoming-September-2025-Conferences
13 Aug 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/sarepta-sells-174m-arrowhead-stock-stretch-cash-runway-transfers-shares-pay-half-milestone
13 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250813527219/en/Sarepta-Therapeutics-Announces-Advancement-of-siRNA-Collaboration-and-Sale-of-Arrowhead-Equity-Investment
ABOUT THIS PAGE